BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24126537)

  • 1. Natural history of Huntington disease.
    Dorsey ER; Beck CA; Darwin K; Nichols P; Brocht AF; Biglan KM; Shoulson I;
    JAMA Neurol; 2013 Dec; 70(12):1520-30. PubMed ID: 24126537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a large group of individuals with huntington disease and their relatives enrolled in the COHORT study.
    ; Dorsey E
    PLoS One; 2012; 7(2):e29522. PubMed ID: 22359536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurology and natural history of patients with indeterminate CAG repeat length mutations of the Huntington disease gene.
    Panegyres PK; Goh JG
    J Neurol Sci; 2011 Feb; 301(1-2):14-20. PubMed ID: 21147489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate and correlates of weight change in Huntington's disease.
    Hamilton JM; Wolfson T; Peavy GM; Jacobson MW; Corey-Bloom J;
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):209-12. PubMed ID: 14742590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
    ; Biglan KM; Shoulson I; Kieburtz K; Oakes D; Kayson E; Shinaman MA; Zhao H; Romer M; Young A; Hersch S; Penney J; Marder K; Paulsen J; Quaid K; Siemers E; Tanner C; Mallonee W; Suter G; Dubinsky R; Gray C; Nance M; Bundlie S; Radtke D; Kostyk S; Baic C; Caress J; Walker F; Hunt V; O'Neill C; Chouinard S; Factor S; Greenamyre T; Wood-Siverio C; Corey-Bloom J; Song D; Peavy G; Moskowitz C; Wesson M; Samii A; Bird T; Lipe H; Blindauer K; Marshall F; Zimmerman C; Goldstein J; Rosas D; Novak P; Caviness J; Adler C; Duffy A; Wheelock V; Tempkin T; Richman D; Seeberger L; Albin R; Chou KL; Racette B; Perlmutter JS; Perlman S; Bordelon Y; Martin W; Wieler M; Leavitt B; Raymond L; Decolongon J; Clarke L; Jankovic J; Hunter C; Hauser RA; Sanchez-Ramos J; Furtado S; Suchowersky O; Klimek ML; Guttman M; Sethna R; Feigin A; Cox M; Shannon B; Percy A; Dure L; Harrison M; Johnson W; Higgins D; Molho E; Nickerson C; Evans S; Hobson D; Singer C; Galvez-Jimenez N; Shannon K; Comella C; Ross C; Saint-Hilaire MH; Testa C; Rosenblatt A; Hogarth P; Weiner W; Como P; Kumar R; Cotto C; Stout J; Brocht A; Watts A; Eberly S; Weaver C; Foroud T; Gusella J; MacDonald M; Myers R; Fahn S; Shults C
    JAMA Neurol; 2016 Jan; 73(1):102-10. PubMed ID: 26569098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Huntington disease: clinical and genetic study in a Spanish population].
    Solís Pérez MP; Palau Martínez F; Burguera Hernández JA; Salazar Cifré A
    Neurologia; 1995 Nov; 10(9):362-6. PubMed ID: 8554791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
    Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
    Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic characteristics in patients with Huntington's disease from China.
    Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
    Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations of intermediate allele carriers in Huntington disease.
    Cubo E; Ramos-Arroyo MA; Martinez-Horta S; Martínez-Descalls A; Calvo S; Gil-Polo C;
    Neurology; 2016 Aug; 87(6):571-8. PubMed ID: 27402890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis.
    Long JD; Mills JA; Leavitt BR; Durr A; Roos RA; Stout JC; Reilmann R; Landwehrmeyer B; Gregory S; Scahill RI; Langbehn DR; Tabrizi SJ;
    JAMA Neurol; 2017 Nov; 74(11):1352-1360. PubMed ID: 28975278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease.
    HORIZON Investigators of the Huntington Study Group and European Huntington's Disease Network
    JAMA Neurol; 2013 Jan; 70(1):25-33. PubMed ID: 23108692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive signs in prodromal Huntington disease.
    Stout JC; Paulsen JS; Queller S; Solomon AC; Whitlock KB; Campbell JC; Carlozzi N; Duff K; Beglinger LJ; Langbehn DR; Johnson SA; Biglan KM; Aylward EH
    Neuropsychology; 2011 Jan; 25(1):1-14. PubMed ID: 20919768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.
    Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
    Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease.
    Marder K; Gu Y; Eberly S; Tanner CM; Scarmeas N; Oakes D; Shoulson I;
    JAMA Neurol; 2013 Nov; 70(11):1382-8. PubMed ID: 24000094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huntington's disease.
    Ha AD; Fung VS
    Curr Opin Neurol; 2012 Aug; 25(4):491-8. PubMed ID: 22772878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD.
    Long JD; Paulsen JS;
    Mov Disord; 2015 Oct; 30(12):1664-72. PubMed ID: 26340420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington's disease.
    Bonelli RM; Beal MF
    Handb Clin Neurol; 2012; 106():507-26. PubMed ID: 22608641
    [No Abstract]   [Full Text] [Related]  

  • 19. Huntington's disease: looking beyond the movement disorder.
    Morreale MK
    Adv Psychosom Med; 2015; 34():135-42. PubMed ID: 25832519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
    J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.